Journal article
Protocol for an Economic Evaluation of the Quitlink Randomized Controlled Trial for Accessible Smoking Cessation Support for People With Severe Mental Illness
R Sweeney, M Moodie, AL Baker, R Borland, D Castle, C Segan, A Turner, J Attia, PJ Kelly, L Brophy, B Bonevski, JM Williams, D Baird, SL White, K McCarter
Frontiers in Psychiatry | FRONTIERS MEDIA SA | Published : 2019
Abstract
Introduction: Smoking is a major cause of disease burden and reduced quality of life for people with severe mental illness (SMI). It places significant resource pressure on health systems and financial stress on smokers with SMI (SSMI). Telephone-based smoking cessation interventions have been shown to be cost effective in general populations. However, evidence suggests that SSMI are less likely to be referred to quitlines, and little is known about the effectiveness and cost effectiveness of such interventions that specifically target SSMI. The Quitlink randomized controlled trial for accessible smoking cessation support for SSMI aims to bridge this gap. This paper describes the protocol fo..
View full abstractGrants
Awarded by NHMRC
Funding Acknowledgements
This study is supported by an NHMRC Project Grant titled "Quitlink: Accessible smoking cessation support for people living with severe and enduring mental illness" (APP1139125).